PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Component Development Laboratory, NHS Blood and Transplant, Cambridge, UK.\', \'Quality Monitoring, NHS Blood and Transplant, London, UK.\', \'Technical & Scientific Development, NHS Blood and Transplant, London, UK.\', \'Centre for Haematology, Imperial College London, London, UK.\', \'Clinical Services Directorate, NHS Blood and Transplant, London, UK.\', \'Radcliffe Department of Medicine, University of Oxford, and NIHR Oxford Biomedical Research Centre, Oxford, UK.\', \'Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.\', \'Department of Haematology, University of Cambridge, Cambridge, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/trf.16723
?:hasPublicationType
?:journal
  • Transfusion
is ?:pmid of
?:pmid
?:pmid
  • 34757639
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.645
?:rankingScore_hIndex
  • 120
?:title
  • Evaluating apheresis platelets at reduced dose as a contingency measure for extreme shortages.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all